Adnkronos The new oral risdiplam formulation has brought about a truly significant change in everyday life, perfectly aligned with the goal of promoting autonomy, independence, and full social reintegration. It is a drug that does not require temperature-controlled storage, is well tolerated, and is easily transportable to any setting, such as the workplace.
This makes the person much more independent from the physical presence in the hospital,” explained Valeria Sansone, professor at the University of Milan and director of the NeMo Clinical Center in Milan, during the event “Brunch & Science: Let's talk about spinal muscular atrophy – The evolution of SMA treatment: when innovation paves the way to independence,” promoted by Roche Italia in Milan.
https://www.youtube.com/watch?v=csPa16MEyYk